GeoVax Labs, Inc.

GeoVax Labs, Inc. is aiming for the underserved niche of immunocompromised people who are unable to benefit from the current crop of US Food and Drug Administration-authorized COVID-19 vaccines with

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AiPharma Joins Effort To Develop Fujifi

Vaccines are a hot area of development and investment, spurred by renewed awareness of the critical public health role they play and the enormous commercial success of the COVID-19 vaccines that have

On 23 March, after eight weeks of idling, BravoVax finally returned to operations. But the road to recovery has just started for the Wuhan, China-based vaccines developer. “We had to rely on ourselves